Primary Record
LCL161
- In stock
- 9,472 g
- Purity
- 99.3 %
- CAS
- 1005342-46-0
Compound Identifiers & Properties
- CAS
- 1005342-46-0
- PubChem CID
- 24737642
- SMILES
- C[C@@H](C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C3=NC(=CS3)C(=O)C4=CC=C(C=C4)F)NC
- Canonical SMILES
- CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(C(=O)c2ccc(F)cc2)cs1)C1CCCCC1
Names & Synonyms
- LCL161
- LCL-161
- 1005342-46-0
- LCL 161
- Nvp-lcl 161
- Smac Mimetic LCL161
- RefChem:152599
- 6TNS415Y3P
- C26H33FN4O3S
- NVP-LCL161
- UNII-6TNS415Y3P
- MFCD23160049
- D0J7ZF
- CHEMBL2431768
- DTXSID501025866
- GTPL7912
- SCHEMBL1275369
- LCL 161 [WHO-DD]
- AOB4073
- EX-A533
- CHEBI:193137
- (s)-n-((s)-1-cyclohexyl-2-((s)-2-(4-(4-fluorobenzoyl)thiazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)-2-(methylamino)propanamide
- DTXCID101510120
- GLXC-03701
- LCL-161?
- 2508AH
- BDBM50441356
- NSC772868
- s7009
- ZINC95929260
- AKOS027422741
- CCG-269696
- CS-1630
- DB12085
- NSC-772868
- NCGC00378579-07
- NCGC00378579-08
- (2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide
- AC-32971
- BC600325
- BP-25378
- CID:24737642
- FL103735
- HY-15518
- SC-94311
- SY069614
- SID:441325578
- A3541
- FT-0773823
- NS00073098
- -yl)-2-oxoethyl)-2-(methylamino)propanamide
- J3.566.398C
- A11928
- Z-3226
- A897412
- C574246
- Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-
- BRD-K08248804-001-01-8
- Q27079405
- B0084-462558
- (S)-N-((S)-1-cyclohexyl-2-((S)-2-(4-(4-fluorobenzoyl)thiazol-2-yl)pyrrolidin-1
- LCL161, 98%, inhibitor of Apoptosis Protein (IAP) family of proteins - 100MG 100mg
- (2S)-N-((1S)-1-cyclohexyl-2-((2S)-2-(4-(4-fluorobenzoyl)-1,3-thiazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)-2-(methylamino)propanamide
- (2S)-N-((1S)-1-cyclohexyl-2-((2S)-2-(4-(4-fluorobenzoyl)-1,3-thiazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)-2-methylaminopropanamide
- (2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylaminopropanamide
- (2S)-N-[(1S)-1-Cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-propanamide
- (2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)thiazol-2-yl]pyrrolidin-1-yl]-2-oxo-ethyl]-2-(methylamino)propanamide
- (2S)-N-[(1S)-1-cyclohexyl-2-{(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl]-2-(methylamino)propanamide
- (S)-N-((S)-1-Cyclohexyl-2-{(S)-2-[4-(4-fluorobenzoyl)thiazol-2- yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide
- (S)-N-[(S)-1-Cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)propanamide
- (S)-N-[(S)-1-Cyclohexyl-2-[(S)-2-[4-(4-fluorobenzoyl)thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide
- N-[(1S)-1-Cyclohexyl-2-{(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]-1-pyrrolidinyl}-2-oxoethyl]-N2-methylalaninamide
- N-[(1S)-1-cyclohexyl-2-{(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl]-N(2)-methyl-L-alaninamide
- N-[(1S)-1-cyclohexyl-2-{(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl]-N~2~-methyl-L-alaninamide
- PROPANAMIDE, N-((1S)-1-CYCLOHEXYL-2-((2S)-2-(4-(4-FLUOROBENZOYL)-2-THIAZOLYL)-1-PYRROLIDINYL)-2-OXOETHYL)-2-(METHYLAMINO)-, (2S)-
- Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-;Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-